Christopher R Flowers Selected Research

B-Cell Lymphoma (Lymphoma, B Cell)

4/2024	Defining Primary Refractory Large B-cell Lymphoma.
11/2023	Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy.
1/2023	Positron emission tomography derived metrics in relapsed or refractory large B-cell lymphoma with residual disease before autologous stem cell transplant.
1/2023	Adjunct Therapy with T Regulatory Cells Decreases Inflammation and Preserves the Anti-Tumor Activity of CAR T Cells.
1/2023	Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNγ-expressing CD8 T cells.
1/2023	Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma.
1/2023	Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response.
1/2023	A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy.
12/2022	Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement.
11/2022	A polyamine-centric, blood-based metabolite panel predictive of poor response to CAR-T cell therapy in large B cell lymphoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher R Flowers Research Topics

Disease

68	Neoplasms (Cancer) 04/2024 - 06/2007
41	Lymphoma (Lymphomas) 04/2024 - 06/2007
39	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2024 - 12/2010
36	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 05/2024 - 06/2007
22	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2024 - 09/2005
22	B-Cell Lymphoma (Lymphoma, B Cell) 04/2024 - 02/2010
13	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2023 - 10/2013
11	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 09/2005
9	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 09/2013
8	Multiple Myeloma 01/2019 - 10/2010
7	Hematologic Neoplasms (Hematological Malignancy) 10/2022 - 08/2011
6	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 12/2014
5	Inflammation (Inflammations) 01/2023 - 11/2019
5	Leukemia 10/2018 - 01/2007
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2018 - 01/2007
4	Venous Thromboembolism 04/2024 - 01/2023
4	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 11/2020 - 05/2015
4	Autoimmune Diseases (Autoimmune Disease) 01/2016 - 08/2014
3	Paralysis (Palsy) 04/2024 - 01/2023
3	Pulmonary Embolism 01/2023 - 06/2013
3	Venous Thrombosis (Deep-Vein Thrombosis) 01/2023 - 06/2013
3	Neutropenia 12/2022 - 03/2014
3	Disease Progression 02/2019 - 02/2016
3	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 07/2015 - 01/2011
2	Hemorrhage 01/2023 - 10/2020
2	Human Influenza (Influenza) 07/2021 - 01/2019
2	Peripheral Nervous System Diseases (PNS Diseases) 10/2020 - 11/2015
2	Fatigue 06/2020 - 10/2013
2	T-Cell Lymphoma (Lymphoma, T Cell) 11/2019 - 07/2015
2	Pneumonia (Pneumonitis) 10/2018 - 03/2014
2	Fever (Fevers) 10/2018 - 02/2013

Drug/Important Bio-Agent (IBA)

44	Rituximab (Mabthera)FDA Link 05/2024 - 10/2009
17	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2024 - 04/2012
14	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2024 - 04/2012
13	Prednisone (Sone)FDA LinkGeneric 04/2024 - 07/2012
13	Vincristine (Oncovin)FDA LinkGeneric 11/2023 - 04/2012
12	Chimeric Antigen ReceptorsIBA 01/2024 - 01/2018
8	ibrutinibIBA 03/2024 - 01/2017
8	VaccinesIBA 01/2022 - 06/2007
7	polatuzumab vedotinIBA 05/2024 - 10/2020
6	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2017
5	obinutuzumabIBA 05/2024 - 01/2019
5	AnthracyclinesIBA 04/2024 - 01/2011
5	axicabtagene ciloleucelIBA 11/2023 - 01/2021
5	Alkylating AgentsIBA 11/2023 - 09/2013
5	Lenalidomide (CC 5013)FDA Link 11/2023 - 06/2020
5	CytokinesIBA 01/2023 - 01/2018
5	AntigensIBA 11/2019 - 07/2011
5	Bortezomib (Velcade)FDA Link 11/2017 - 10/2009
4	Bendamustine Hydrochloride FDA Link 09/2023 - 01/2017
4	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 04/2012
4	idelalisibIBA 01/2021 - 03/2014
4	Benzene (Benzole)IBA 01/2020 - 09/2013
4	Etoposide (VP 16)FDA LinkGeneric 01/2016 - 08/2012
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2013 - 08/2011
3	Monoclonal AntibodiesIBA 05/2024 - 09/2013
3	venetoclaxIBA 05/2024 - 01/2020
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2012
3	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023 - 01/2017
3	AntibodiesIBA 01/2023 - 06/2007
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 04/2012
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022 - 02/2013
3	carboxyl radical (COO-)IBA 01/2021 - 01/2019
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2020 - 06/2013
3	AnticoagulantsIBA 10/2020 - 06/2013
3	Immunoglobulin Idiotypes (Idiotype, Immunoglobulin)IBA 11/2016 - 06/2007
3	Busulfan (Busulfex)FDA Link 01/2016 - 08/2012
3	fludarabineIBA 11/2015 - 05/2015
3	plerixafor FDA Link 09/2013 - 10/2011
2	zanubrutinibIBA 03/2024 - 11/2023
2	Biological FactorsIBA 01/2024 - 06/2020
2	Immune Checkpoint InhibitorsIBA 01/2023 - 04/2017
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2019
2	InterferonsIBA 01/2023 - 11/2020
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2022
2	apixabanIBA 01/2023 - 10/2020
2	RivaroxabanIBA 01/2023 - 10/2020
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 04/2012
2	pembrolizumabIBA 01/2022 - 04/2017
2	Influenza Vaccines (Influenza Vaccine)FDA Link 07/2021 - 01/2019
2	RadiumIBA 01/2021 - 01/2021
2	ublituximabIBA 11/2019 - 02/2019
2	umbralisibIBA 11/2019 - 02/2019
2	CarcinogensIBA 11/2019 - 04/2016
2	purineIBA 10/2018 - 09/2013
2	Antiviral Agents (Antivirals)IBA 10/2018 - 10/2011
2	Clindamycin (Cleocin)FDA LinkGeneric 10/2018 - 02/2013

Therapy/Procedure

90	Therapeutics 04/2024 - 01/2007
32	Drug Therapy (Chemotherapy) 01/2023 - 09/2005
13	Stem Cell Transplantation 01/2023 - 09/2005
7	Immunotherapy 01/2023 - 06/2007
6	Transplantation 10/2020 - 01/2007
5	Radiotherapy 01/2021 - 09/2005
4	Salvage Therapy 11/2017 - 12/2013
3	Precision Medicine 01/2020 - 06/2017
3	Hematopoietic Stem Cell Transplantation 10/2018 - 06/2014
3	Hematopoietic Stem Cell Mobilization 09/2013 - 08/2011
2	Injections 01/2023 - 01/2022
2	Combined Modality Therapy 01/2021 - 12/2016
2	Photopheresis 11/2020 - 11/2010